Generali gets bids below book value for BSI-sources
Written by Reuters: Company NewsGLOBAL MARKETS-Shares near 5-yr high as central bank rally rolls on
Written by Reuters: Company NewsDon Wordell is passing on his passion for fishing and golf to his young children, but given his record as a stockpicker, they may eventually want to follow in their dad's professional footsteps as well. Wordell manages the RidgeWorth
...Regeneron Pharmaceuticals' Impressive Pipeline - Barrons.com
Written by Barron's Most Emailed TodayRegeneron Pharmaceuticals (REGN: Nasdaq) By Roth Capital Partners ($266.16, May 6, 2013) We maintain our Buy rating on Regeneron Pharmaceuticals and are raising our price target from $200 to $314. Our thesis remains unchanged and we believe
...UPDATE 2-Diageo turns to insider to replace CEO Walsh
Written by Reuters: Company NewsAdecco first-quarter profit drops 40 percent
Written by Reuters: Company NewsNikkei rallies above 14,000 for first time since June 2008
Written by Reuters: Company NewsStock Market: Charts Point to More Gains
Written by Barron's Most Emailed TodayIn the fairy tale, Goldilocks rated everything as too hot, too cold or just right. Friday's non-farm payrolls report for April was indeed just right, with enough growth to satisfy economists and not too much too worry Fed-watchers. Afte
...ChartLabPro Appeals to Stock-Market Technicians and Tech Wannabes
Written by Barron's Most Emailed TodayStock-market technicians have a new tool with which to ply their trades. ChartLabPro is a Website just out of beta testing that provides some highly graphical ways for traders to keep up with the market's twists and turns.
Phase one of ChartLabPro's ( chartlabpro.com [1] ) graduated rollout provides subscribers with a portfolio tracker, charting,
...